drugset / Trial / NCT01134991

Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients

NCT01134991

Phase 2 Terminated 21 enrolled Vyne Therapeutics Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

Acne rosacea is a chronic acneiform disorder affecting both the skin and the eye. It is a syndrome of undetermined etiology characterized by both vascular and papulopustular components involving the face and occasionally the neck and upper trunk. This is a pilot phase II study to evaluate the tolerability and safety and to monitor the clinical efficacy of Topical Minocycline Foam FXFM244 in moderate to severe Rosacea patients.

Timeline

Start
2010-06
Primary completion
2014-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 1 % Topical
Subject Minocycline Small molecule 4 % Topical

Indications